Quantamental Technologies LLC Chemo Centryx, Inc. Transaction History

Quantamental Technologies LLC

$105 Million
Q3 2023

Shares

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 15, 2022	BUY	$15.36 - $27.51 $233,195 - $417,656	15,182 New	15,182 $376,000
Q1 2022 May 16, 2022	SELL	$22.22 - $39.12 $443,555 - $780,913	-19,962 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$18.38 - $40.5 $366,901 - $808,461	19,962 New	19,962 $727,000
Q3 2019 Nov 08, 2019	SELL	$6.47 - $8.96 $31,741 - $43,957	-4,906 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$8.31 - $14.85 $40,768 - $72,854	4,906 New	4,906 $46,000

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantamental Technologies LLC with notifications on news.